Johnson Bixby & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
Johnson Bixby & Associates's MRK Position: Q2 2026 in Review
Johnson Bixby & Associates increased its Merck (MRK) stake by 0.73% in Q2 2026, buying an estimated $3.63K and bringing the position to 4,249 shares worth $546K. The position accounts for 0.06% of the portfolio, ranked #69.
Johnson Bixby & Associates first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $616K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Johnson Bixby & Associates held 4,249 shares of Merck worth $546K as of Q2 2026.
- Johnson Bixby & Associates bought 31 Merck shares in Q2 2026, an estimated $3.63K.
- Merck made up 0.06% of Johnson Bixby & Associates's portfolio in Q2 2026, its #69 holding.
- Johnson Bixby & Associates first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
- Johnson Bixby & Associates's Merck position peaked at $616K in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Johnson Bixby & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.